Progyny, Inc. P/S ratio

P/S ratio of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/S ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its sales per share. It is used by investors mainly because it’s less volatile than P/E and less subject to accounting manipulation. A low P/S ratio compare to historical average or other companies in the same industry might indicate undervaluation.

Highlights and Quick Summary

Current P/S ratio of Progyny, Inc. is 10.63 (as of December 30, 2020)
  • P/S ratio for the quarter ending September 29, 2021 was 10.6 (a -8.33% decrease compared to previous quarter)
  • Year-over-year quarterly P/S ratio decreased by -0.36%
  • Annual P/S ratio for 2020 was 10.63 (a 329.14% increase from previous year)
  • Annual P/S ratio for 2019 was 2.48 (a 300.21% increase from previous year)
  • Annual P/S ratio for 2018 was 0.62 (a 0.0% decrease from previous year)
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/S ratio of Progyny, Inc.

Most recent P/S ratioof PGNY including historical data for past 10 years.

Interactive Chart of P/S ratio of Progyny, Inc.

Progyny, Inc. P/S ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 10.6 11.56 10.08
2020 10.63 8.2 8.09 6.8 10.63
2019 2.48 0.62 0.62 0.62 2.48
2018 0.62 0.62
2017 0.62

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.